Skip to main navigation Skip to search Skip to main content

Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor

  • Ji Hyun Kam
  • , Hakyoung Yoon
  • , Hun Young Yoon
  • , Kidong Eom
  • , Hyun Jeong Sung
  • , Jung Hyun Kim*
  • *Corresponding author for this work
  • Konkuk University

Research output: Contribution to journalJournal articlepeer-review

Abstract

A puppy was diagnosed with lymphangiosarcoma associated with lymphedema based on lymphogi and histopathology. The lesions resolved after toceranib therapy, and the dog remains in remission 1 year This is the first report of a successful outcome following oral toceranib as first-line therapy for lymphangiosan in a dog.

Original languageEnglish
Pages (from-to)367-372
Number of pages6
JournalCanadian Veterinary Journal
Volume59
Issue number4
StatePublished - 2018.04

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor'. Together they form a unique fingerprint.

Cite this